| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | 307 | 1.854 | 2.809 | 2.027 | 744 | 1.666 | 2.271 | 2.696 | 3.506 |
| Total Income - EUR | 0 | 307 | 1.854 | 2.809 | 2.027 | 744 | 1.666 | 2.271 | 2.696 | 3.506 |
| Total Expenses - EUR | 0 | 234 | 0 | 0 | 0 | 0 | 0 | 0 | 441 | 554 |
| Gross Profit/Loss - EUR | 0 | 73 | 1.854 | 2.809 | 2.027 | 744 | 1.666 | 2.271 | 2.255 | 2.952 |
| Net Profit/Loss - EUR | 0 | 65 | 1.788 | 2.725 | 1.966 | 724 | 1.616 | 2.211 | 1.949 | 2.546 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Rodenis Med S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 9.972 | 9.870 | 9.703 | 9.525 | 9.341 | 9.164 | 8.960 | 8.988 | 9.678 | 9.356 |
| Current Assets | 0 | 8 | 986 | 36 | 1.952 | 2.642 | 638 | 2.505 | 3.721 | 6.496 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 320 | 719 |
| Cash | 0 | 8 | 986 | 36 | 1.952 | 2.642 | 638 | 2.505 | 3.401 | 5.777 |
| Shareholders Funds | 734 | 791 | 2.566 | 5.244 | 7.109 | 7.699 | 9.144 | 11.383 | 13.297 | 15.769 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 9.238 | 9.087 | 8.122 | 4.316 | 4.183 | 4.107 | 454 | 110 | 102 | 83 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8690
|
|||||||||
Comments - Rodenis Med S.r.l.